221 related articles for article (PubMed ID: 30198862)
1. Clinical risk analysis of non-visualized sentinel lymph node in breast cancer.
Zhang J; Pei J; Liu H
Cancer Biomark; 2018; 23(2):179-183. PubMed ID: 30198862
[TBL] [Abstract][Full Text] [Related]
2. Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
Magnoni F; Corso G; Gilardi L; Pagan E; Massari G; Girardi A; Ghidinelli F; Bagnardi V; Galimberti V; Grana CM; Veronesi P
Future Oncol; 2022 Jan; 18(2):193-204. PubMed ID: 34882010
[TBL] [Abstract][Full Text] [Related]
3. Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis.
Verheuvel NC; Voogd AC; Tjan-Heijnen VCG; Siesling S; Roumen RMH
Breast Cancer Res Treat; 2018 Jan; 167(1):147-156. PubMed ID: 28861665
[TBL] [Abstract][Full Text] [Related]
4. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
5. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
Dong LF; Xu SY; Long JP; Wan F; Chen YD
J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
[TBL] [Abstract][Full Text] [Related]
6. Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
Tatara T; Mukohara T; Shimono Y; Yamasaki T; Imamura Y; Funakoshi Y; Toyoda M; Kiyota N; Takao S; Kono S; Kakeji Y; Minami H
J Surg Oncol; 2018 May; 117(6):1131-1136. PubMed ID: 29193094
[TBL] [Abstract][Full Text] [Related]
7. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
Barron AU; Hoskin TL; Boughey JC
Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
[TBL] [Abstract][Full Text] [Related]
8. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.
Ding J; Jiang L; Wu W
Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123
[TBL] [Abstract][Full Text] [Related]
10. Prediction of nonsentinel lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Öz B; Akcan A; Doğan S; Abdulrezzak Ü; Aslan D; Sözüer E; Emek E; Akyüz M; Elmalı F; Ok E
Asian J Surg; 2018 Jan; 41(1):12-19. PubMed ID: 27591153
[TBL] [Abstract][Full Text] [Related]
11. [Application value on localization and evaluation of sentinel lymph nodes in early-stage breast cancer with CT lymphography].
Wang PG; Tan HN; Wang B; Xiao HJ; Gao JB
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(35):2762-2765. PubMed ID: 28954335
[No Abstract] [Full Text] [Related]
12. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
Yang X; Ma X; Yang W; Shui R
Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
[TBL] [Abstract][Full Text] [Related]
14. A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
Wang NN; Yang ZJ; Wang X; Chen LX; Zhao HM; Cao WF; Zhang B
Breast Cancer; 2018 Nov; 25(6):629-638. PubMed ID: 29696563
[TBL] [Abstract][Full Text] [Related]
15. Prospective study found that peripheral lymph node sampling reduced the false-negative rate of sentinel lymph node biopsy for breast cancer.
Han C; Yang B; Zuo WS; Liu YS; Zheng G; Yang L; Zheng MZ
Chin J Cancer; 2016 Apr; 35():35. PubMed ID: 27044285
[TBL] [Abstract][Full Text] [Related]
16. Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
Umekita Y; Ohi Y; Iwaya O; Souda M; Sagara Y; Tamada S; Yotsumoto D; Tanimoto A
Histopathology; 2018 Dec; 73(6):916-922. PubMed ID: 30035819
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Positive Rate Predicts Non-Sentinel Lymph Node Metastasis in Breast Cancer.
Wang X; Zhang G; Zuo Z; Zhu Q; Wu S; Zhou Y; Mao F; Lin Y; Shen S; Zhang X; Qin X; Yan C; Ma X; Shi Y; Sun Q
J Surg Res; 2022 Mar; 271():59-66. PubMed ID: 34839110
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.
Liu R; Chen J; Cao W; Li T; Liao Y; Li Y
Medicine (Baltimore); 2024 Mar; 103(9):e37263. PubMed ID: 38428869
[TBL] [Abstract][Full Text] [Related]
19. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
20. Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes.
Den Toom IJ; Bloemena E; van Weert S; Karagozoglu KH; Hoekstra OS; de Bree R
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):961-968. PubMed ID: 27561671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
